Niacin, food intake and cardiovascular effects

This publication has 13 references indexed in Scilit:

• A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
  Nature Medicine, 2024
• Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment
  JACC, 2021
• Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
  Journal of Internal Medicine, 2005
• Influence of Extended-Release Nicotinic Acid on Nonesterified Fatty Acid Flux in the Metabolic Syndrome With Atherogenic Dyslipidemia
  The American Journal of Cardiology, 2005
• Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) α and δ and PPAR coactivator 1α in human skeletal muscle, but not lipid regulatory genes
  Journal of Molecular Endocrinology, 2004
• Sympathetic Activity as the Cause of the Morning Increase in Cardiac Events
  Circulation, 1995
• Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.
  Circulation, 1989
• Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid
  Acta Medica Scandinavica, 1988
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  JACC, 1986
• Clofibrate and Niacin in Coronary Heart Disease
  JAMA, 1975